# Transcat Inc: financial statements, quarterly

TRNS · Nasdaq · CIK 99302 · [Technology](/sectors/technology.md) · fiscal year ends Mar 27

Pages: [Overview](/companies/trns.md) · [Financials](/companies/trns/financials.md) · [Filings](/companies/trns/filings.md) · [Insiders](/companies/trns/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/trns/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-09-23) | Q3 FY2023 (2023-12-23) | Q4 FY2023 (2024-03-30) | Q1 FY2024 (2024-06-29) | Q2 FY2024 (2024-09-28) | Q3 FY2024 (2024-12-28) | Q4 FY2024 (2025-03-29) | Q1 FY2025 (2025-06-28) | Q2 FY2025 (2025-09-27) | Q3 FY2025 (2025-12-27) | Q4 FY2025 (2026-03-28) | Q1 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [62.8](/filings/0001437749-24-033612.md) | [65.2](/filings/0001437749-25-002899.md) | [70.9 d](/filings/0001437749-26-018588.md) | [66.7](/filings/0001437749-25-025074.md) | [67.8](/filings/0001437749-25-033338.md) | [66.8](/filings/0001437749-26-002800.md) | [77.1 d](/filings/0001437749-26-018588.md) | [76.4](/filings/0001628280-26-052738.md) | [82.3](/filings/0001437749-25-033338.md) | [83.9](/filings/0001437749-26-002800.md) | [89.3 d](/filings/0001437749-26-018588.md) | [92.9](/filings/0001628280-26-052738.md) |
| Cost of revenue | $m | [42.7](/filings/0001437749-24-033612.md) | [44.2](/filings/0001437749-25-002899.md) | [46.9 d](/filings/0001437749-26-018588.md) | [44.1](/filings/0001437749-25-025074.md) | [46.6](/filings/0001437749-25-033338.md) | [47.1](/filings/0001437749-26-002800.md) | [51.2 d](/filings/0001437749-26-018588.md) | [50.6](/filings/0001628280-26-052738.md) | [55.5](/filings/0001437749-25-033338.md) | [58.6](/filings/0001437749-26-002800.md) | [58.9 d](/filings/0001437749-26-018588.md) | [62.2](/filings/0001628280-26-052738.md) |
| Gross profit | $m | [20.1](/filings/0001437749-24-033612.md) | [20.9](/filings/0001437749-25-002899.md) | [24.0 d](/filings/0001437749-26-018588.md) | [22.7](/filings/0001437749-25-025074.md) | [21.2](/filings/0001437749-25-033338.md) | [19.7](/filings/0001437749-26-002800.md) | [25.9 d](/filings/0001437749-26-018588.md) | [25.8](/filings/0001628280-26-052738.md) | [26.8](/filings/0001437749-25-033338.md) | [25.3](/filings/0001437749-26-002800.md) | [30.5 d](/filings/0001437749-26-018588.md) | [30.7](/filings/0001628280-26-052738.md) |
| Operating income | $m | [1.6](/filings/0001437749-24-033612.md) | [4.3](/filings/0001437749-25-002899.md) | [9.2 d](/filings/0001437749-26-018588.md) | [5.1](/filings/0001437749-25-025074.md) | [3.7](/filings/0001437749-25-033338.md) | [2.1](/filings/0001437749-26-002800.md) | [6.9 d](/filings/0001437749-26-018588.md) | [5.3](/filings/0001628280-26-052738.md) | [3.5](/filings/0001437749-25-033338.md) | [0.1](/filings/0001437749-26-002800.md) | [4.3 d](/filings/0001437749-26-018588.md) | [3.7](/filings/0001628280-26-052738.md) |
| Interest expense | $m | [0.9](/filings/0001437749-24-033612.md) | [0.1](/filings/0001437749-24-002702.md) | [0.1 d](/filings/0001437749-24-018456.md) | [0.1](/filings/0001437749-25-025074.md) | [0.1](/filings/0001437749-25-033338.md) | [0.2](/filings/0001437749-26-002800.md) | [0.5 d](/filings/0001437749-26-018588.md) | [0.5](/filings/0001628280-26-052738.md) | [1.3](/filings/0001437749-25-033338.md) | [1.5](/filings/0001437749-26-002800.md) | [1.4 d](/filings/0001437749-26-018588.md) | [1.5](/filings/0001628280-26-052738.md) |
| Income tax | $m | [0.3](/filings/0001437749-24-033612.md) | [0.9](/filings/0001437749-25-002899.md) | [2.7 d](/filings/0001437749-26-018588.md) | [0.8](/filings/0001437749-25-025074.md) | [0.4](/filings/0001437749-25-033338.md) | [0.8](/filings/0001437749-26-002800.md) | [1.8 d](/filings/0001437749-26-018588.md) | [1.3](/filings/0001628280-26-052738.md) | [0.8](/filings/0001437749-25-033338.md) | [(0.3)](/filings/0001437749-26-002800.md) | [0.9 d](/filings/0001437749-26-018588.md) | [0.9](/filings/0001628280-26-052738.md) |
| Net income | $m | [0.5](/filings/0001437749-25-002899.md) | [3.3](/filings/0001437749-25-002899.md) | [6.9 d](/filings/0001437749-26-018588.md) | [4.4](/filings/0001437749-26-002800.md) | [3.3](/filings/0001437749-26-002800.md) | [2.4](/filings/0001437749-26-002800.md) | [4.5 d](/filings/0001437749-26-018588.md) | [3.3](/filings/0001628280-26-052738.md) | [1.3](/filings/0001437749-26-002800.md) | [(1.1)](/filings/0001437749-26-002800.md) | [1.9 d](/filings/0001437749-26-018588.md) | [1.3](/filings/0001628280-26-052738.md) |
| Diluted EPS | $ per share | [0.06](/filings/0001437749-24-033612.md) | [0.38](/filings/0001437749-25-002899.md) | not reported | [0.48](/filings/0001437749-25-025074.md) | [0.35](/filings/0001437749-25-033338.md) | [0.25](/filings/0001437749-26-002800.md) | not reported | [0.35](/filings/0001628280-26-052738.md) | [0.14](/filings/0001437749-25-033338.md) | [(0.12)](/filings/0001437749-26-002800.md) | not reported | [0.14](/filings/0001628280-26-052738.md) |
| Basic EPS | $ per share | [0.06](/filings/0001437749-24-033612.md) | [0.39](/filings/0001437749-25-002899.md) | not reported | [0.49](/filings/0001437749-25-025074.md) | [0.36](/filings/0001437749-25-033338.md) | [0.26](/filings/0001437749-26-002800.md) | not reported | [0.35](/filings/0001628280-26-052738.md) | [0.14](/filings/0001437749-25-033338.md) | [(0.12)](/filings/0001437749-26-002800.md) | not reported | [0.14](/filings/0001628280-26-052738.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating, us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-09-23) | Q3 FY2023 (2023-12-23) | FY2023 (2024-03-30) | Q1 FY2024 (2024-06-29) | Q2 FY2024 (2024-09-28) | Q3 FY2024 (2024-12-28) | FY2024 (2025-03-29) | Q1 FY2025 (2025-06-28) | Q2 FY2025 (2025-09-27) | Q3 FY2025 (2025-12-27) | FY2025 (2026-03-28) | Q1 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.2](/filings/0001437749-23-029757.md) | [35.2](/filings/0001437749-24-002702.md) | [19.6](/filings/0001437749-25-018483.md) | [22.7](/filings/0001437749-24-025176.md) | [23.8](/filings/0001437749-24-033612.md) | [4.6](/filings/0001437749-25-002899.md) | [1.5](/filings/0001437749-26-018588.md) | [1.9](/filings/0001437749-25-025074.md) | [5.1](/filings/0001437749-25-033338.md) | [3.5](/filings/0001437749-26-002800.md) | [4.9](/filings/0001628280-26-052738.md) | [6.7](/filings/0001628280-26-052738.md) |
| Current assets | $m | [65.2](/filings/0001437749-23-029757.md) | [98.8](/filings/0001437749-24-002702.md) | [105](/filings/0001437749-25-018483.md) | [94.3](/filings/0001437749-24-025176.md) | [95.2](/filings/0001437749-24-033612.md) | [76.6](/filings/0001437749-25-002899.md) | [78.0](/filings/0001437749-26-018588.md) | [79.7](/filings/0001437749-25-025074.md) | [85.7](/filings/0001437749-25-033338.md) | [80.8](/filings/0001437749-26-002800.md) | [92.5](/filings/0001628280-26-052738.md) | [95.7](/filings/0001628280-26-052738.md) |
| Total assets | $m | [248](/filings/0001437749-23-029757.md) | [281](/filings/0001437749-24-002702.md) | [288](/filings/0001437749-25-018483.md) | [324](/filings/0001437749-24-025176.md) | [324](/filings/0001437749-24-033612.md) | [386](/filings/0001437749-25-002899.md) | [385](/filings/0001437749-26-018588.md) | [393](/filings/0001437749-25-025074.md) | [485](/filings/0001437749-25-033338.md) | [473](/filings/0001437749-26-002800.md) | [480](/filings/0001628280-26-052738.md) | [493](/filings/0001628280-26-052738.md) |
| Current liabilities | $m | [28.1](/filings/0001437749-23-029757.md) | [29.4](/filings/0001437749-24-002702.md) | [33.5](/filings/0001437749-25-018483.md) | [31.8](/filings/0001437749-24-025176.md) | [26.5](/filings/0001437749-24-033612.md) | [31.7](/filings/0001437749-25-002899.md) | [34.0](/filings/0001437749-26-018588.md) | [27.3](/filings/0001437749-25-025074.md) | [35.3](/filings/0001437749-25-033338.md) | [36.6](/filings/0001437749-26-002800.md) | [39.6](/filings/0001628280-26-052738.md) | [38.4](/filings/0001628280-26-052738.md) |
| Total liabilities | $m | [110](/filings/0001437749-23-029757.md) | [62.6](/filings/0001437749-24-002702.md) | [62.4](/filings/0001437749-25-018483.md) | [61.4](/filings/0001437749-24-025176.md) | [54.8](/filings/0001437749-24-033612.md) | [105](/filings/0001437749-25-002899.md) | [98.4](/filings/0001437749-26-018588.md) | [100](/filings/0001437749-25-025074.md) | [189](/filings/0001437749-25-033338.md) | [176](/filings/0001437749-26-002800.md) | [180](/filings/0001628280-26-052738.md) | [190](/filings/0001628280-26-052738.md) |
| Long-term debt | $m | [51.0](/filings/0001437749-23-029757.md) | [2.4](/filings/0001437749-24-002702.md) | [1.8](/filings/0001437749-25-018483.md) | [1.2](/filings/0001437749-24-025176.md) | [0.6](/filings/0001437749-24-033612.md) | [39.5](/filings/0001437749-25-002899.md) | [30.9](/filings/0001437749-26-018588.md) | [33.2](/filings/0001437749-25-025074.md) | [112](/filings/0001437749-25-033338.md) | [99.9](/filings/0001437749-26-002800.md) | [99.9](/filings/0001628280-26-052738.md) | [110](/filings/0001628280-26-052738.md) |
| Current portion of debt | $m | [2.3](/filings/0001437749-23-029757.md) | [2.3](/filings/0001437749-24-002702.md) | [2.3](/filings/0001437749-25-018483.md) | [2.4](/filings/0001437749-24-025176.md) | [2.4](/filings/0001437749-24-033612.md) | [2.4](/filings/0001437749-25-002899.md) | [1.8](/filings/0001437749-26-018588.md) | [1.2](/filings/0001437749-25-025074.md) | [0.0](/filings/0001437749-25-033338.md) | [0.0](/filings/0001437749-26-002800.md) | [0.0](/filings/0001437749-26-018588.md) | not reported |
| Shareholders' equity | $m | [138](/filings/0001437749-25-002899.md) | [218](/filings/0001437749-25-002899.md) | [225](/filings/0001437749-26-018588.md) | [262](/filings/0001437749-26-002800.md) | [269](/filings/0001437749-26-002800.md) | [281](/filings/0001437749-26-002800.md) | [287](/filings/0001628280-26-052738.md) | [293](/filings/0001628280-26-052738.md) | [295](/filings/0001437749-26-002800.md) | [297](/filings/0001437749-26-002800.md) | [301](/filings/0001628280-26-052738.md) | [303](/filings/0001628280-26-052738.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-09-23) | Q3 FY2023 (2023-12-23) | Q4 FY2023 (2024-03-30) | Q1 FY2024 (2024-06-29) | Q2 FY2024 (2024-09-28) | Q3 FY2024 (2024-12-28) | Q4 FY2024 (2025-03-29) | Q1 FY2025 (2025-06-28) | Q2 FY2025 (2025-09-27) | Q3 FY2025 (2025-12-27) | Q4 FY2025 (2026-03-28) | Q1 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [8.4 d](/filings/0001437749-24-033612.md) | [10.9 d](/filings/0001437749-25-002899.md) | [5.7 d](/filings/0001437749-26-018588.md) | [8.9](/filings/0001437749-25-025074.md) | [6.8 d](/filings/0001437749-25-033338.md) | [12.6 d](/filings/0001437749-26-002800.md) | [10.6 d](/filings/0001437749-26-018588.md) | [3.6](/filings/0001628280-26-052738.md) | [12.9 d](/filings/0001437749-25-033338.md) | [12.1 d](/filings/0001437749-26-002800.md) | [6.2 d](/filings/0001437749-26-018588.md) | [8.8](/filings/0001628280-26-052738.md) |
| Capital expenditure | $m | [2.7 d](/filings/0001437749-24-033612.md) | [3.7 d](/filings/0001437749-25-002899.md) | [4.2 d](/filings/0001437749-26-018588.md) | [3.7](/filings/0001437749-25-025074.md) | [4.0 d](/filings/0001437749-25-033338.md) | [2.9 d](/filings/0001437749-26-002800.md) | [2.7 d](/filings/0001437749-26-018588.md) | [4.6](/filings/0001628280-26-052738.md) | [4.4 d](/filings/0001437749-25-033338.md) | [2.7 d](/filings/0001437749-26-002800.md) | [3.6 d](/filings/0001437749-26-018588.md) | [4.0](/filings/0001628280-26-052738.md) |
| Share repurchases | $m | [1.9 d](/filings/0001437749-24-033612.md) | [0.0 d](/filings/0001437749-25-002899.md) | [2.7 d](/filings/0001437749-26-018588.md) | [1.6](/filings/0001437749-25-025074.md) | [1.4 d](/filings/0001437749-25-033338.md) | [0.2 d](/filings/0001437749-26-002800.md) | [0.4 d](/filings/0001437749-26-018588.md) | [0.0](/filings/0001628280-26-052738.md) | [0.1 d](/filings/0001437749-25-033338.md) | [(0.0) d](/filings/0001437749-26-002800.md) | [0.4 d](/filings/0001437749-26-018588.md) | [1.9](/filings/0001628280-26-052738.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-09-24) | Q3 FY2022 (2022-12-24) | Q1 FY2023 (2023-06-24) | Q2 FY2023 (2023-09-23) | Q3 FY2023 (2023-12-23) | Q1 FY2024 (2024-06-29) | Q2 FY2024 (2024-09-28) | Q3 FY2024 (2024-12-28) | Q1 FY2025 (2025-06-28) | Q2 FY2025 (2025-09-27) | Q3 FY2025 (2025-12-27) | Q1 FY2026 (2026-06-27) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [7,646](/filings/0001437749-23-029757.md) | [7,666](/filings/0001437749-24-002702.md) | [7,762](/filings/0001437749-24-025176.md) | [7,948](/filings/0001437749-24-033612.md) | [8,752](/filings/0001437749-25-002899.md) | [9,196](/filings/0001437749-25-025074.md) | [9,282](/filings/0001437749-25-033338.md) | [9,326](/filings/0001437749-26-002800.md) | [9,389](/filings/0001628280-26-052738.md) | [9,399](/filings/0001437749-25-033338.md) | [9,329](/filings/0001437749-26-002800.md) | [9,473](/filings/0001628280-26-052738.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 9,359,813 at 2026-07-31, from the cover of the [10-Q filed 2026-08-04](/filings/0001628280-26-052738.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.